Industrializing yeast as a drug repurposing platform for inherited metabolic diseases
Mathuravani A. Thevandavakkam, Natalie E. Long, Briannna M. Roel, Kristin A. Kantautas, Shiri Zakin, Van K Duesterberg, Ethan O. Perlstein
This paper presents a yeast-based drug repurposing platform for inherited metabolic diseases, demonstrating its efficacy through case studies and showing potential to accelerate therapy development.
bioRxiv · Aug 23, 2024 · PreprintSystems Biology